Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
ESOC 2022
AAN 2022
CONy 2022
AD/PD 2022
World Sleep 2022
ACTRIMS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Multiple Sclerosis and Related Disorders
2:06
MS susceptibility in Latin American populations
Victor Rivera
• 24 Feb 2022
1:53
Developing a natural model for MS
Jorge Alvarez
• 25 Feb 2022
5:28
Using machine learning predictions to design more efficient MS clinical trials
David Li-Bland
• 2 Mar 2022
2:52
Impact of ocrelizumab disruption on RRMS
Kelly Cotchett
• 25 Feb 2022
1:23
Research developments in MOGAD
Michael Levy
• 25 Feb 2022
1:32
The earliest stages of MS: understanding susceptibility and the MS prodrome
Adil Harroud
• 25 Feb 2022
1:27
SAkura: long-term safety and efficacy of satralizumab for NMOSD
Michael Levy
• 25 Feb 2022
4:50
Biology or poor trial design…What underlies remyelination trial failures in MS?
Gavin Giovannoni
• 1 Mar 2022
1:01
Tailoring treatment in MS with new S1P receptor modulators
Jiwon Oh
• 25 Feb 2022
3:51
BTK inhibitors: Investigating disease relevant mechanisms in multiple sclerosis
Rochelle Benoit
• 28 Feb 2022
1:13
Paramagnetic rim lesions in multiple sclerosis
Jiwon Oh
• 25 Feb 2022
2:07
What is the latest progress in gene research in MS?
Lars Alfredsson
• 25 Feb 2022
2:18
Investigating the MS prodrome and RIS to advance understanding in MS
Adil Harroud
• 25 Feb 2022
1:39
Recent progress and future needs in NMOSD treatment
Michael Levy
• 25 Feb 2022
1:46
Potential of BTK inhibitors in MS
Rochelle Benoit
• 28 Feb 2022
1:44
Investigating the impact of at-home training and tDCS on cognitive function in MS
Leigh Charvet
• 26 Feb 2022
Previous
1
2
3
4
5
6
7
8
9
…
23
Next